Literature DB >> 9593719

Specific regions of contact between human T-cell leukemia virus type I Tax protein and DNA identified by photocross-linking.

A L Kimzey1, W S Dynan.   

Abstract

The human T-cell leukemia virus type I Tax protein forms a ternary complex on DNA in association with a host factor, the cyclic AMP response element-binding protein (CREB). An understanding of the precise geometry of this complex has been elusive. We have used photocross-linking to investigate Tax-DNA contacts. Our data show that Tax contacts the DNA at two symmetric positions 14 nucleotides apart on either side of the Tax responsive element. The presence of symmetric, widely separated regions of contact suggests that at least two molecules of Tax are present in the complex. Mapping the contacts onto a three-dimensional model of the CREB-DNA binary complex shows that they lie on the same face of the DNA near the regions where the N termini of the CREB bZIP domains enter the major groove. This location correlates well with previous evidence that CREB amino acid residues immediately N-terminal to the bZIP domain are crucial for the formation of the ternary complex. The limited number of cross-links observed suggests that contacts are primarily with the phosphate backbone and does not support the idea that a major structural element of the Tax protein inserts into the major or minor grooves of the DNA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593719     DOI: 10.1074/jbc.273.22.13768

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation.

Authors:  K E Scoggin; A Ulloa; J K Nyborg
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 2.  Insight into the tumor suppressor function of CBP through the viral oncoprotein tax.

Authors:  K Van Orden; J K Nyborg
Journal:  Gene Expr       Date:  2000

3.  Tax abolishes histone H1 repression of p300 acetyltransferase activity at the human T-cell leukemia virus type 1 promoter.

Authors:  Kasey L Konesky; Jennifer K Nyborg; Paul J Laybourn
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

4.  Human T-cell leukemia virus open reading frame II encodes a posttranscriptional repressor that is recruited at the level of transcription.

Authors:  Ihab Younis; Kathleen Boris-Lawrie; Patrick L Green
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 5.  CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection.

Authors:  Yujie Liu; Michael R Nonnemacher; Brian Wigdahl
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

6.  The human T-cell leukemia virus type 1 tax protein confers CBP/p300 recruitment and transcriptional activation properties to phosphorylated CREB.

Authors:  Timothy R Geiger; Neelam Sharma; Young-Mi Kim; Jennifer K Nyborg
Journal:  Mol Cell Biol       Date:  2007-12-10       Impact factor: 4.272

7.  Human T-lymphotropic virus type 1 oncoprotein tax promotes S-phase entry but blocks mitosis.

Authors:  Min-Hui Liang; Thomas Geisbert; Yao Yao; Steven H Hinrichs; Chou-Zen Giam
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

8.  The proto-oncogene Bcl3, induced by Tax, represses Tax-mediated transcription via p300 displacement from the human T-cell leukemia virus type 1 promoter.

Authors:  Young-Mi Kim; Neelam Sharma; Jennifer K Nyborg
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

9.  Tax recruitment of CBP/p300, via the KIX domain, reveals a potent requirement for acetyltransferase activity that is chromatin dependent and histone tail independent.

Authors:  Sara A Georges; Holli A Giebler; Philip A Cole; Karolin Luger; Paul J Laybourn; Jennifer K Nyborg
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

10.  The HTLV-1 tax protein cooperates with phosphorylated CREB, TORC2 and p300 to activate CRE-dependent cyclin D1 transcription.

Authors:  Y-M Kim; T R Geiger; D I Egan; N Sharma; J K Nyborg
Journal:  Oncogene       Date:  2010-01-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.